The additionally glycosylated variant of human sex hormone-binding globulin (SHBG) is linked to estrogen-dependence of breast cancer

Breast Cancer Research and Treatment

Volumn 54, Issue 2, 1999, Pages 101-107

  Becchis, Marzia ^a   Frairia, Roberto ^a   Ferrera, Patrizia ^a   Fazzari, Annamaria ^a   Ondei, Sabrina ^a   Alfarano, Alda ^b   Coluccia, Claudio ^a   Biglia, Nicoletta ^c   Sismondi, Piero ^c   Fortunati, Nicoletta ^a,d  

^a MOLINETTE HOSPITAL   (Italy)

^b UNIVERSITY OF TURIN   (Italy)

^c UNIVERSITY OF TURIN   (Italy)

^d Laboratorio di Endocrinologia   (Italy)

Author keywords

Estrogen dependent breast cancer; SBP; SHBG; Variant

Indexed keywords

ASPARAGINE; ASPARTIC ACID; CARRIER PROTEIN; SEX HORMONE BINDING GLOBULIN;

AGE; AMINO ACID SUBSTITUTION; ARTICLE; BREAST CANCER; BREAST DISEASE; CONTROLLED STUDY; EXON; FEMALE; GENE AMPLIFICATION; HUMAN; IMMUNOBLOTTING; MAJOR CLINICAL STUDY; NUCLEOTIDE SEQUENCE; POINT MUTATION; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN GLYCOSYLATION; PROTEIN VARIANT; RESTRICTION FRAGMENT LENGTH POLYMORPHISM;

AMINO ACID SUBSTITUTION; ARGININE; ASPARAGINE; BASE SEQUENCE; BREAST; BREAST NEOPLASMS; CELL DIVISION; ESTRADIOL; EXONS; FEMALE; FIBROCYSTIC BREAST DISEASE; GLYCOSYLATION; HUMANS; POINT MUTATION; POLYMORPHISM, RESTRICTION FRAGMENT LENGTH; REFERENCE VALUES; SEX HORMONE-BINDING GLOBULIN; VARIATION (GENETICS);

EID: 0032981807     PISSN: 01676806     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1006100929670     Document Type: Article

References (19)

1. Osborne CK, Yochmowitz MG, Knight WA III, McGuire WL: The value of estrogen and progesterone receptors in treatment of breast cancer. Cancer 46: 2884-2888, 1988
2. Edwards DP, Chamness GC, McGuire WL: Estrogen and progesterone receptor proteins in breast cancer. Biochim Biophys Acta 560: 457-486, 1979
3. Benner SE, Clark GM, McGuire WL: Review: Steroid receptors, cellular kinetics, and lymph node status as prognostic factors in breast cancer. Am J Med Sci 296: 59-66, 1988
4. McGuire WL: Hormone receptors: their role in predicting prognosis and response to endocrine therapy. Semin Oncol 5: 428-433, 1978
5. Aronica SM, Katzenellenbogen BS: Progesterone receptor regulation in uterine cells: stimulation by estrogens, cyclic adenosine 3′,5′-monophosphate, and insulin-like growth factor I and suppression by anti-estrogens and protein kinase inhibitors. Endocrinology 128: 2045-2052, 1991
6. Ince BA, Montano MM, Katzenellonbogen BS: Activation of trascriptionally inactive human estrogen receptors by cyclic adenosine 3′,5′-monophosphate and ligands including antiestrogens. Mol Endo 8: 1397-1406, 1994
7. Hammond GL: Potential functions of plasma steroid binding proteins. Trends Endocrinol Metab 6: 298-304, 1995
8. Fortunati N, Fissore F, Fazzari A, Berta L, Benedusi-Pagliano E, Frairia R: Biological relevance of the interaction between sex steroid binding protein and its receptor of MCF-7 cells: effect on the estradiol-induced cell proliferation. J Steroid Biochem Molec Biol 55: 435-444, 1993
9. Porto CS, Musto NA, Bardin CW, Gunsalus GL: Binding of an extracellular steroid binding globulin to membranes and soluble receptors from human breast cancer cells (MCF-7 cells). Endocrinology 130: 2931-2936, 1992
10. Catalano MG, Comba A, Fazzari A, Benedusi-Pagliano E, Sherveglieri M, Revelli A, Massobrio M, Frairia R, Fortunati N: Sex steroid binding protein receptor (SBP-R) is related to a reduced proliferation rate in human breast cancer. Breast Cancer Res Treat 42: 227-234, 1997
11. Fortunati N, Fissore F, Fazzari A, Becchis M, Comba A, Catalano MG, Berta L, Frairia R: Sex steroid binding protein (SBP, SHBG) exerts a negative control on estradiol action in MCF-7 cells (human breast cancer) through cAMP and PKA. Effect on estradiol-induced cell proliferation. Endocrinology 137: 686-692, 1996
12. Van Baelen H, Convents R, Cailleau J, Heyns W: Genetic variation of human Sex Hormone-Binding Globulin: evidence for a worldwide bi-allelic gene. J Clin Endocrinol Metab 75: 135-139, 1992
13. Hardy DO, Carino C, Catterall JF, Larrea F: Molecular characterization of a genetic variant of the steroid hormone-binding globulin gene in heterozygous subjects. J Clin Endocrinol Metab 80: 1253-1256, 1995
14. Power SGA, Bocchinfuso WP, Pallesen M, Warmel-Rodenhiser S, Van Baelen H, Hammond GI: Molecular analysis of a human Sex Hormone-Binding Globulin variant: evidence for an additional carbohydrate chain. J Clin Endocrinol Metab 75: 1066-1070, 1992
15. Bocchinfuso WP, Ma KL, Lee WM, Warmel-Rodenhiser S, Hammond GL: Selective removal of glycosylation sites from Sex Hormone-Binding Globulin by site-directed mutagenesis. Endocrinology 131: 2331-2336, 1992
16. Avvakumov GV, Zhuk NI, Sterl'chyonok OA: Biological function of the carbohydrate component of the human sex steroid binding globulin. Biokhimiya 53: 838-841, 1988
17. Lahiri DK, Nurnberger JI Jr: A rapid non-enzymatic method for the preparation of HMW-DNA from blood for RFLP studies. Nucleic Acid Res 19: 5444, 1991
18. Cousin P, De Chaud H, Grenot C, Lejeune H, Pugeat M, with the technical assistance of Baret C and Brébant C: Human variant Sex Hormone-Binding Globulin (SHBG) with an additional carbohydrate chain has a reduced clearance rate in rabbit. J Clin Endocrinol Metab 83: 235-240, 1998
19. Staquet MJ: Cancer therapy: prognostic factors and criteria of response. Raven Press, New York, 1975